Trial Profile
A phase I study to assess safety and tolerability of Chikungunya fever vaccine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Chikungunya virus vaccine (Primary)
- Indications Chikungunya virus infections
- Focus Adverse reactions
- 25 Jun 2014 New trial record
- 12 Jun 2014 Positive interim results were obtained according to a Themis Bioscience media release.